Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment options: herpes simplex viruses.

Noah S Scheinfeld1

  • 1Department of Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Avenue, Suite 118, New York, NY 10025, USA. scheinfeld@earthlink.net

Skinmed
|September 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.

JAMA dermatology·2014
Same author

Drug-induced photoallergic and phototoxic reactions - an update.

Expert opinion on drug safety·2014
Same author

Natroba (spinosad) 0.9% suspension topical suspension for head lice.

Skinmed·2011
Same author

Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).

Skinmed·2011
Same author

Therapeutic review 2009-2010.

Skinmed·2011
Same author

Vibativ (telavancin) for complicated skin and skin structure infections.

Skinmed·2010
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

Herpes labialis, a common lip infection caused by Herpes Simplex Virus-1, presents as painful blisters. Prompt diagnosis and antiviral treatment, such as valacyclovir, effectively resolve the outbreak.

Area of Science:

  • Dermatology
  • Virology

Background:

  • Herpes labialis, commonly known as cold sores, is a prevalent viral infection affecting the perioral region.
  • It is typically caused by the Herpes Simplex Virus-1 (HSV-1).

Purpose of the Study:

  • To report a case of herpes labialis diagnosed and treated in a 35-year-old woman.
  • To highlight the diagnostic methods and therapeutic response in managing this common condition.

Main Methods:

  • Clinical presentation of vesiculopustules on erythematous bases around the lips.
  • Diagnostic workup included Tzanck smear and viral culture.
  • Treatment administered was oral valacyclovir.

Main Results:

  • Tzanck smear revealed multinucleated giant cells, suggestive of viral infection.

Related Experiment Videos

  • Viral culture confirmed the presence of Herpes Simplex Virus-1.
  • The patient experienced complete resolution of the lip eruption within one week of initiating valacyclovir treatment.

    • Conclusions:

    • Herpes labialis is effectively diagnosed using Tzanck smear and viral culture.
    • Valacyclovir is an effective antiviral medication for treating herpes labialis, leading to rapid symptom resolution.